Capstone Therapeutics Corp. (CAPS)
(Delayed Data from NSDQ)
$1.36 USD
-0.04 (-2.86%)
Updated Aug 6, 2025 03:59 PM ET
After-Market: $1.36 0.00 (0.00%) 6:16 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Capstone Therapeutics Corp. has a market cap of $0.22M, which represents its share price of $1.40 multiplied by its outstanding shares number of 0.16M. As a small-cap company, CAPS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CAPS 1.36 -0.04(-2.86%)
Will CAPS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CAPS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CAPS
Capstone Holding (CAPS) Launches Corporate Development Team to Boost Acquisitions
Capstone announces formation of Corporate Development team
Capstone Holding Corp. Accelerates Acquisition Strategy with Launch of Dedicated Corporate ...
Capstone Holding Corp. Accelerates Acquisition Strategy with Launch of Dedicated Corporate Development Team
Capstone Therapeutics (CAPS) Plans to Sell Over 4 Million Common Shares